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The present study was designed to determine the level of malondialdehyde (MDA) concentration, 
serum c reactive protein (CRP) and CD4+ T cells in type 2 diabetes mellitus in a view to assessing the 
complications associated with the non specific activ tion of CD4+ T cells. A total of 80 subjects aged between 
18 and 50 years gave their consent to participate in the study. They consist of 40 known type 2 diabetes 
mellitus and 40 aged matched apparently healthy control subjects on routine checkup. Malondialdehyde 
concentration was determined by spectrophotometric method. Serum c reactive protein was determined by 
enzyme-linked immunosorbent assay method. CD4+ T cells were estimated using Partec cyflow counter. There 
was a significant increase in MDA concentration, CRP and CD4+ T cells in type 2 diabetes mellitus subjects 
when compared with the aged matched control group (P < 0.05). Type 2 diabetes mellitus causes an increased 
production of free radicals which is possibly linked to the complications associated with non specific activation 
of CD4+ T cells. 
© 2015 International Formulae Group. All rights reserved. 
 




The prevalence of diabetes mellitus is 
increasing rapidly worldwide and the  World 
Health Organization (2003) has predicted that 
by 2030 the number of adults with diabetes 
would have almost doubled worldwide, from 
177 million in 2000 to 370 million (Rowley 
and Bezold, 2012). Diabetes mellitus is a 
complex syndrome characterized by absolute 
or relative insulin deficiency leading to 
hyperglycemia and an altered metabolism of 
glucose, fat, and protein (Remuzzi et al., 
2002; Caramori and Mauer, 2003; Wolf and 
Ritz, 2003). 
Since more than 90% of the global 
cases of diabetes mellitus are type 2, it is 
evident that the epidemic is mainly due to the 
escalation of the causes of type 2 diabetes 
mellitus. According to the current definition, 
two fasting glucose measurement above 126 
mg/dl (7.0 mmol/L) are considered diagnostic 
for diabetes mellitus or Glycated hemoglobin 
(HbA1C) above 6.5% (Sayalah et al., 2001; 
WHO, 2003; Motala, 2008; Chinenye et al., 
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2008). Experimental evidence demonstrated 
that c reactive proteins is a sensitive 
physiological biomarker of sub clinical 
systemic inflammation which is associated 
with hyperglycemia, insulin resistance and 
overt  type 2 diabetes mellitus (Su et al., 
2010). 
Lipid peroxidation is a well established 
mechanism of cellular injury and is used as an 
indicator of oxidative stress in cells and 
tissues. The measurement of malondialdehyde 
is widely used as an indicator of lipid 
peroxidation and increased level of the 
peroxidation products have been associated 
with a variety of acute and chronic 
pathophysiological processes including type 2 
diabetes mellitus (Killic et al., 2003). Recent 
research suggests that patients with elevated 
basal level of CRP are at an increased risk of 
diabetes mellitus, hypertension and 
cardiovascular disease (Clearfield, 2005). 
However; could the elevation of MDA and 
CRP play a major role in diabetogenesis? This 
question, if explored, may open new doors in 
the understanding of the complication 
associated with type 2 diabetes mellitus. Thus, 
the present study was designed to determine 
the level of MDA, CRP and CD4+ T cells in 
type 2 diabetes mellitus in a view to assessing 
the complications associated with the non 
specific activation of CD4+ T cells. 
 
MATERIALS AND METHODS 
Subjects 
A total of 80 subjects aged between 18 
and 60 years gave their consent to participate 
in the study. They consist of 40 known type 2 
diabetes mellitus and 40 aged matched 
apparently healthy control subjects on routine 
checkup. They were confirmed to be diabetics 
and non diabetics respectively using the 
glucose oxidase method as previously 




Both males and females were included 
in the study. 
 
Exclusion criteria 
Pregnant women and those diagnosed 
with other systemic diseases were excluded 
from this study. 
 
Physiological measurements 
The subjects resting systolic blood 
pressure and diastolic blood were measured 
from the right arm as described by Musa et al. 
(2002). Using an automated digital electronic 
BP monitor (Omron digital BP monitor, 
Model 11 EM 403c; Tokyo Japan. 
 
Collection of blood samples 
       Nine milliliters of fasting venous blood 
was collected from the medial cubital vein 
using vacutainer and needle from each of the 
subjects and shared equally into ethylene 
diamine tetra acetic acid, sodium fluoride 
potassium oxalate and plain containers. 
 
Determination of blood glucose level 
Glucose oxidase method was used in 
the determination of blood glucose as 
previously described by Ehiaghe et al. (2013). 
In brief, 10 µl of the standard or test samples 
was added to 1000 µl of glucose reagent 1, 
mixed and incubated for 25 minutes at 20 
0C.The absorbance of the standard and test 
samples was measured against the reagent 
blank within 60 minutes at a wavelength of 
540 nm using a spectrophotometer. 
 
Determination of serum c reactive protein 
Enzyme-linked immunosorbent assay 
(ELISA) was used in the determination of the 
level of c reactive protein in the serum. The 
assay employs an antibody specific for c 
reactive protein coated on a 96 well plate. 
Briefly, 100 µl of the assay diluents was 
added to each well. 50 µl of standard or 
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sample(s) was added per well and mixture was 
incubated for 2 hours. The solution was 
discarded and microplates washed four times 
with 300 µl of 1X wash solution. 200 µl c 
reactive protein conjugate was added to the 
standard or sample(s) and covered with a 
sealing tape. It was incubated at room 
temperature for 2 hours. The solution was 
discarded and microplates washed four times 
with 300 µl of 1X wash solution. 200 µl of 
tetraethyl benzidine substrate was added to 
each well and incubated for 30 minutes at 
room temperature in the dark with gentle 
shaking. 50 µl of stop solution was added to 
each microplate. The intensity of the color 
developed was measured at 450 nm 
wavelength using stat fax® 4700 micro strip 
reader as previously described by Ehiaghe et 
al. (2013). 
 
CD4+ T cell count estimation 
CD4+ T cell count was estimated using 
Partec cyflow counter as described by Partec 
cyflow counter (2006). 
 
Malondialdehyde estimation 
Reagent 1: (Trichloroacetic acid 17.5%); 
Reagent -2 :( Trichloroacetic acid 70%); 
Reagent – 3: (Thiobarbituric acid 0.6%) TBA 
Malondialdehyde in the serum was 
determined as conjugated with TBA. The 
reaction was performed    in 18 × 150 mm 
Pyrex test tube labeled as: test and blank, into 
which 1ml each of reagents 1, 2, and 3 was 
added into them respectively. 1 ml of the serum 
was added to the test tube labeled test while 1 
ml of distilled water was added to the test tube 
labeled blank. The tubes were mixed well and 
incubated in boiling bath for 15 minutes, 
allowed to cool. The tubes let to stand at room 
temperature for 20 minutes. Then the tubes 
centrifuged at 2000 rpm for 15 minutes. The 
supernatant layer was read at 534 nm with a 
spectrophotometer. The concentration of MDA 
(µmol/L) was calculated by using the following 
formula: Concentration of the test= Abs (test) –
Abs (blank) / 1.56 x 1000000 as previously 
described by Mossa et al. (2009). 
 
Statistical analysis 
All numerical variables were expressed 
in mean (± SD) and analyzed using one way 
analysis of variance (ANOVA).Using SPSS 
version 20.0. Significant level was considered 
at P < 0.05. 
 
Ethics 
Ethical approval was obtained from the 
ethical committee of the Lahor Research 
Laboratories and Medical centre in Benin 




Our findings revealed that there was no 
significant difference in SBP, DBP, Glucose, 
CRP, CD4+ T cells and MDA concentration of 
the males type 2 diabetes mellitus when 
compared with females type 2 diabetes 
mellitus (P> 0.05). There was also no 
significant difference with males control 
group when compared with females control 
group (P > 0.05), (Table 1). 
There was a significant increase in 
SBP, DBP, Glucose, CRP, CD4+T cells and 
MDA concentration of type 2 diabetes 
mellitus when compared with the aged 
matched control group  (P < 0.05), (Table 2). 
Our finding also revealed a significant 
increase in SBP, DBP, Glucose, CRP, CD4+ T 
cells and MDA  concentration of the male 
type 2 diabetes mellitus when compared with 
the males control group (P < 0.05), (Table 3).  
A significant increase in SBP, DBP, Glucose, 
CRP, CD4+ T cells and MDA concentration of 
the females type 2 diabetes mellitus compared 
with the females control group (P < 0.05), 
(Table 3). 
 




Table 1: Comparison of mean (±SD) SBP (mm.Hg), DBP (mm.Hg), Glucose (mg/dl), CRP (ng/l), 
CD4+ T cell count (cells/µl), and MDA (µmol/L) between type 2 diabetes mellitus (DM) groups and 
the control groups respectively. 
 
Parameter SBP DBP Glucose CRP CD4+ T 
cell count 
MDA 
Male type 2 DM(n=22) 140±10.4 83±7.1 162±43 144±46 660±69 3.1± 0.29 
Female type 2 DM (n=18) 140± 8.8 83± 7.5 151± 41 139±52 661±80 2.9± 0.34 
P- value >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 
Male control group (n=22) 116±3.5 74±4.2 89± 11 1.5± .7 504± 74 1.56±0.4 
Female control group (n=18) 117± 3.3 73± 4.6 88± 14.7 1.8±2.3 508±60 1.49±0.35 
P-value >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 




Table 2:  Comparison of mean (±SD) SBP (mm.Hg), DBP (mm.Hg), Glucose (mg/dl), CRP (ng/l), 
CD4+ T cell count (cells/µl), and MDA (µmol/L) of the type 2 DM with the control groups 
irrespective of gender. 
 
Parameters SBP DBP Glucose CRP CD4+ T cell 
count 
MDA 
Type 2 DM (n=40) 140±1.51 83±1.13 160±6.7 141±7.6 661±75 3.0± 0.05 
Control group (n=40) 116± 0.54 73.4± 0.69 88.5± 2.02 1.7±0.3 506±67 1.53± 0.06 
P- value <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 




Table 3: Comparison of  mean (±SD) SBP (mm.Hg), DBP (mm.Hg), Glucose (mg/dl), CRP (ng/l), 
CD4+ T cell count (cells/µl), and MDA (µmol/L) of   type 2 DM and control groups  with gender 
biased. 
 
Parameter SBP DBP Glucose CRP CD4+ T cell 
count 
MDA 
Male type 2 
DM(n=22) 
140±10.4 83±7.1 162±43 144±46 660±69 3.1± 0.29 
Male control 
group (n=22) 
116±3.5 74±4.2 89± 11 1.5±1.7 504± 74 
 
1.56±0.4 
P- value <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 
Female type 2 
DM (n=18) 
140± 8.8 83± 7.5 151± 41 139±52 661±80 2.9± 0.34 
Female control 
group (n=18) 
117± 3.3 73± 4.6 88± 14.7 1.8±2.3 508±60 1.49±0.35 
P-value <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 
P < 0.05 was considered significant. 
 
 




The prevalence of diabetes mellitus is 
increasing rapidly worldwide and World 
Health Organization (2003) has predicted that 
by 2030 the number of adults with diabetes 
would have almost doubled worldwide. There 
is scarcity of published report on the 
physiochemical changes associated with type 
2 diabetes mellitus in Benin City, hence these 
study. A significant increase in 
malondialdehyde concentration seen in both 
males and females type 2 diabetes mellitus 
subjects as compared with the control groups 
(Tables 2 and 3). This could be attributed to 
the increased production of free radical 
occasioned by the auto-oxidation of glucose 
and lipid peroxidation. This is in accordance 
with these findings. The increased level of 
lipid peroxides can cause oxidative injury to 
blood cells, cross-linking of membrane lipids 
and protein, increasing of cell ageing, 
imbalance of prostacyclin/prostaglandin and 
vasoconstriction (Jain et al., 1996). Our 
findings also revealed that there was no 
significant difference in SBP, DBP, Glucose, 
CRP, CD4+ T cells and MDA concentration of 
the males type 2 diabetes mellitus when 
compared with females type 2 diabetes 
mellitus (Table 1). This may be attributed to 
the common outcome of diabetogenesis 
regardless of gender affiliation. The aberrant 
production of inflammatory cytokines and 
chemokines as well as differential activation 
of T helper cells and monocytes is the 
underlying immunopathological mechanism 
of type 2 diabetes mellitus patients (Lim et al., 
2009). 
The significant increase in CD4+ T 
cells, CRP, SBP and DBP of the diabetics 
groups (Tables 2 and 3) when compared with 
the non diabetics groups (Table 1 and 2). This 
could be linked to the non specific activation 
of the T helper cells by free radical generated 
from the auto-oxidation of glucose, lipid, 
protein peroxidation and a possible 
destruction of endothelial cells of the renal 
and cardiovascular system by the non specific 
mediator released by the activated T cells. 
This is in accordance with the findings. 
Activated T cells can cause injury directly 
through cytotoxic effects and indirectly by 
recruiting and activating macrophages. 
Proinflammatory cytokines secreted by T 
(CD4+, CD8+) cells could activate neighboring 
macrophages directly or by stimulating 
mesangial cell production of colony 
stimulating factor-1 and MCP-1 indirectly. 
Once macrophages have activated, they can 
release nitric oxide, reactive oxygen species, 
IL-1, TNF-α, complement factors, and 
metalloproteinase, all of which promote renal 
injury (Wang and Harris, 2011).  An increased 
body of evidence indicates that immigrated 
blood leukocytes might considerably alter the 
phenotype of endothelial cells and increase 
inflammation of the vascular bed (Endemann 
and Schiffrin, 2004). Endothelial dysfunction 
is associated with most forms of 
cardiovascular disease, such as coronary 
artery disease, chronic renal failure and 
Diabetes mellitus (Stehouwer, 2004). The 
interaction of renal tissue macrophages and T 
cells produces various reactive oxygen 
species, proinflammatory cytokines, 
metalloproteinase, and growth factor, which 
modulate the local response and increase 
inflammation within the cells (Yamagishi et 
al., 2007). Experimental evidence 
demonstrated that c reactive proteins is a 
sensitive physiological biomarker of sub 
clinical systemic inflammation which is 
associated with hyperglycemia, insulin 
resistance and overt  type 2 diabetes mellitus                       
(Su et al., 2010). 
 
Conclusion 
It was observed that type 2 diabetes 
mellitus causes an increased production of 
free radical which is possibly linked to the 
non specific activation of CD4+ T cells. The 
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molecular mechanism underlying the 
complications associated with the non specific 
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